Skip to main content
EG

Enhanc3D Genomics

Enhanc3D Genomics utilizes its GenLink3D platform to analyze the 3D organization of DNA, focusing on the impact of genetic variations in non-coding regions on disease progression. This approach enables the identification of new biomarkers and treatment targets for complex conditions such as cancer, aging, and autoimmune diseases.

Cambridge, United KingdomFounded 2020333K+ followers
Updated 20 months ago

Funding

$13.9M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.

BG
Funding rounds are not available yet.

Founders

Product

Problem

The majority of genetic variations impacting complex diseases reside in non-coding regions of the genome, making it difficult to understand their effect on disease progression. Existing methods struggle to interpret how these mutations influence remote genes and contribute to conditions like cancer, aging, and autoimmune disorders. This lack of understanding hinders the identification of effective biomarkers and therapeutic targets.

Solution

Enhanc3D Genomics offers the GenLink3D platform, a functional genomics solution that analyzes the 3D organization of DNA to understand the impact of genetic variations in non-coding regions on disease. The platform leverages 3D genome maps to reveal how these mutations affect remote genes, providing insights into disease mechanisms. By elucidating these complex relationships, GenLink3D enables the discovery of novel biomarkers and treatment targets for complex diseases such as cancer, aging, and autoimmune conditions. The platform offers a suite of products including GENLINK Connect, GENLINK Profile, GENLINK Response, and GENLINK Hub.

Target Audience

The primary audience includes researchers and pharmaceutical companies focused on developing precision medicine approaches for cancer, aging, and autoimmune diseases.

Features

  • Analyzes the 3D organization of DNA to understand the impact of genetic variations.
  • Leverages 3D genome maps to identify how mutations affect remote genes.
  • Identifies novel biomarkers and treatment targets for complex diseases.
  • Offers GENLINK Connect for [Description Needed].
  • Offers GENLINK Profile for [Description Needed].
  • Offers GENLINK Response for [Description Needed].
  • Offers GENLINK Hub for [Description Needed].
This profile is AI-generated and may contain inaccuracies.